1. Home
  2. STBA vs AZTA Comparison

STBA vs AZTA Comparison

Compare STBA & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$40.12

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$35.05

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
AZTA
Founded
1902
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Industrial Machinery/Components
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
STBA
AZTA
Price
$40.12
$35.05
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$41.25
$43.60
AVG Volume (30 Days)
210.7K
667.4K
Earning Date
10-23-2025
11-21-2025
Dividend Yield
3.59%
N/A
EPS Growth
N/A
N/A
EPS
3.46
N/A
Revenue
$391,893,000.00
$593,821,000.00
Revenue This Year
$7.40
$6.13
Revenue Next Year
$4.94
$5.02
P/E Ratio
$11.60
$66.13
Revenue Growth
1.21
N/A
52 Week Low
$30.84
$23.91
52 Week High
$43.67
$55.64

Technical Indicators

Market Signals
Indicator
STBA
AZTA
Relative Strength Index (RSI) 59.35 59.20
Support Level $38.27 $34.34
Resistance Level $40.70 $38.20
Average True Range (ATR) 1.01 1.48
MACD 0.08 0.21
Stochastic Oscillator 77.50 65.42

Price Performance

Historical Comparison
STBA
AZTA

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Share on Social Networks: